OPIANT PHARMACEUTICALS, INC. reports

Company location: Santa Monica, CA
Fiscal year end: 31 December

OPIANT PHARMACEUTICALS, INC. has filed 578 SEC EDGAR filings since 11 Jan 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 101-125 of 545 matching filings.

Per page

25

Current page

5

S-8 File 333-263636

S-8

Filing date: 17 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-38193

10-K

Filing date: 15 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 15 Mar 2022
Reporting date: 15 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-90404

SC 13G/A filing

Filing date: 10 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jan 2022
Reporting date: 27 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jan 2022
Reporting date: 27 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-90404

SC 13G/A filing

Filing date: 27 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Jan 2022
Reporting date: 10 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 07 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 13 Dec 2021
Reporting date: 09 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38193

10-Q

Filing date: 12 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 12 Nov 2021
Reporting date: 11 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38193

8-K

Filing date: 08 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 23 Sep 2021
Reporting date: 21 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Sep 2021
Reporting date: 14 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Sep 2021
Reporting date: 16 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Sep 2021
Reporting date: 14 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .